DCVC | Activity | F4
DCVC Activity Every public signal F4 has attached to this firm, with sources and cross-entity links.
Milestone
Portfolio company Radiant received a $750 million U.S. Army award for advanced nuclear microreactor development. Radiant
DCVC co-led Emerald AI's $150 million Series A round to transform data centers into intelligent grid-responsive assets. Investment
DCVC joined a $100 million seed round for Callosum, which is building a new orchestration layer for heterogeneous AI. Callosum
Milestone
Portfolio company Relation announced a strategic collaboration with GSK for its MORGAN cellular foundation model, worth up to $110 million in upfront and milestone payments. Relation
Essay
DCVC published its fourth annual Deep Tech Opportunities Report, themed 'Back to Fundamentals in an Age of Exponential Change', covering energy, AI, quantum, manufacturing, drug discovery, robotics, and defense. 2026 Deep Tech Opportunities Report
New Fund
DCVC is raising $1.3 billion across its flagship seventh fund and a second energy and climate fund, riding the momentum of the Fervo Energy IPO. DCVC raising $1.3B across flagship fund VII and second energy/climate fund
Milestone
Atom Computing was included in a U.S. Department of Commerce quantum investment program, including a $100M equity stake. Atom Computing
Exit
Portfolio company Fervo Energy completed its IPO on Nasdaq under ticker FRVO. Fervo Energy
Investment
Co-led Quantum Motion's $160M Series C to scale silicon-spin quantum computing. Quantum Motion
Investment
Co-led Kanvas Biosciences' $48M Series A for microbiome therapeutics. Kanvas Biosciences
Essay
Published a defense and space thesis highlighting portfolio companies across launch, orbital logistics, earth observation, and drone defense. Startup-built technologies are bringing new ways to dominate in the air and in space
Essay
Published a DCVC Bio thesis on protein-like polymers for intracellular drug delivery. There is an exciting new way to put protein-like drugs inside cells
Exit
Portfolio company Horizon Quantum Computing exited. Horizon Quantum Computing
Horizon Quantum Computing DCVC Investment
Led Proxima's $80M seed round for protein reprogramming therapeutics. Proxima